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Apoptosis after global or focal cerebral ischemia plays a crucial role in mediating cell 
death. In this study, we observed the time point expression of physiologic events involv-
ing apoptosis regulatory proteins after photochemically-induced focal cerebral ische-
mia in Sprague-Dawley rats. Protein expression was evaluated at days 1, 3, and 7 by 
Western blot. Bcl-2, Bax, caspase-3, and phosphorylated Akt (pAkt) activity markedly 
increased in the ischemic hemisphere in a time-dependent manner, not affected. The 
expression of Bcl-2, Bax, and caspase-3 was dramatically changed around day 3, where-
as changes in pAkt expression occurred at day 1. Differential elevation of these apopto-
sis regulatory proteins at various time points indicates that different modes of cell death 
occur in photochemically-induced focal cerebral ischemia in a rat brain.
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INTRODUCTION
Stroke is the major cause of chronic disability and the 
third leading cause of death in humans after cancer and cor-
onary heart disease in developed countries. Because stroke 
causes severe neurological complications, new strategies 
for patients suffering from stroke are needed. Neuropro-
tection in ischemic stroke has been a topic of increasing con-
cern and research. The capacity for neuroprotection de-
pends on multiple factors including the use of an appro-
priate agent at the appropriate time and during the appro-
priate interval.
1
A variety of animal models have been developed for mod-
eling ischemic stroke. Among them, the most common mod-
el of focal ischemia in rats is the occlusion of the middle cere-
bral artery (MCAo) with an intraluminal suture, which me-
chanically occludes the major cerebral arteries.
2 In con-
trast with other models of cerebral ischemia that involve 
mechanical occlusion of blood vessels, the rat photo-
chemical cortical lesion models show endothelial damage, 
resulting in platelet aggregation, thrombosis, and perma-
nent cerebral vascular occlusion.
3 Considering that vas-
cular thrombosis is responsible for more than 70% of hu-
man stroke cases and that only one Food and Drug 
Administration (FDA)-approved therapy exists for the 
treatment of acute ischemic stroke (the thrombolytic tissue 
plasminogen activator, or tPA), this model may be useful 
for understanding the pathobiology of ischemic stroke.
4
Cerebral ischemia/reperfusion (I/R) injury triggers mul-
tiple and distinct but overlapping cell signaling pathways 
that may lead to cell survival or cell damage.
5 Compared 
with global ischemia, focal ischemia is a reduction in blood 
flow to a very specific brain region as in embolic occlusion 
of the specific vessels.
6 There are also significant differ-
ences in the modes of cell death between global and focal 
cerebral ischemia. In focal cerebral ischemia, most of the 
cells in the ischemic core undergo necrosis, but the rim of 
brain tissue that is hypoperfused surrounding the core is 
called the ischemic penumbra, which has the capacity to 
recover if perfusion is improved.
7
In the penumbra, multiple mechanisms lead to apopto-
sis: excitotoxicity and ionic imbalance, oxidative stress, 
and apoptotic-like cell death may all occur and in both cas-
pase-dependent and caspase-independent manners that 
may contribute to delayed ischemic cell death.
8 A quite sim-
plistic view implies poor prospects regarding cell survival 
in the core of the cerebral infarction and therapeutic ex-
pectations to control cell death and cell survival in the 145
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FIG. 1. Representative Western blots showing immunoreactivity
of Bcl-2, Bax, caspase-3, pAkt, and survivin proteins in controls
and in the ischemic hemisphere 1, 3, and 7 days after photochemi-
cally induced focal cerebral ischemia. All proteins were detected
at the predicted molecular size and showed different time point
expression patterns. The results of GAPDH analysis are shown 
as an internal control.
penumbra. In fact, focal cerebral ischemia triggers a cas-
cade of molecular events that produce neuronal death 
ranging from immediate death to that occurring many days 
later, and this phenomenon raises the hypothesis that a 
“therapeutic window” exists during which interventions 
may improve neurological outcome.
9 The aim of neuro-
protection is to prevent delayed neuron apoptosis in the 
zone of the ischemic penumbra. On the basis of our current 
knowledge, many experimental trials have been reported 
to restore this process.
10-12
In the photochemical stroke model, a ring lesion, which 
creates a cortical region of viable tissue surrounded by a 
circular rim of damaged tissue, has been described for the 
study of histological, biochemical, and molecular changes 
associated with the ischemic penumbra.
13 TUNEL stain is 
used to demonstrate apoptotic and nonapoptotic features.
14
Although the expression of pro- and anti-apoptotic fac-
tors and apoptotic cell death sequences have been ex-
tensively investigated, the time point changes in the mech-
anisms of cell death in photochemically induced focal cere-
bral ischemia remain inadequately defined. Previous in-
vestigations have reported on changes in the bcl-2 family 
in this model.
14-16 Therefore, we examined changes in the 
expression of Bcl-2, Bax, caspase-3, phosphorylated Akt 
(pAkt), and survivin by Western blot 1, 3, and 7 days after 
photochemically induced focal cerebral ischemia in the rat. 
MATERIALS AND METHODS
1. Animals and induction of focal cerebral ischemia 
All surgical procedures and postoperative care were per-
formed in accordance with the guidelines of the Chonnam 
National University Animal Care and Usage Committee. 
Twenty male Sprague-Dawley rats weighing between 200 
and 250 g were used in this study. These animals were 
maintained on a 12-h light/dark cycle and were allowed free 
access to food and water. Each rat was anesthetized with 
5% isoflurane and was maintained with 2% isoflurane in 
an oxygen/air mixture with the use of a gas anesthesia mask 
in a stereotaxic frame (Stoelting, Wood Dale, IL, USA). Fo-
cal cortical ischemia was induced by photothrombosis of 
the cortical microvessels using Rose Bengal (RB; Sigma 
Chemical Co., St. Louis, MO, USA) with cold light (Zeiss 
KL1500 LCD, Jena, Germany) as previously described 
with minor modifications.
3,17 The expression of each apop-
tosis associated protein was measured 1, 3, and 7 days after 
the onset of ischemia. Body temperature was maintained 
during surgery at 37±0.5°C with a heating pad controlled 
with a rectal probe. For illumination, a 4.5-mm fiber optic 
bundle from a cold light source was positioned on the ex-
posed skull 0.5 mm anterior to the bregma and 3.7 mm lat-
eral to the midline over the left sensorimotor cortex. The 
brain was illuminated for 10 min after infusion of 50 mg/kg 
of RB in normal saline into the right femoral vein via a mi-
croinjection pump within 1 min. The scalp was sutured and 
the rats were allowed to awake before being returned to 
their cages. The sham-operated control group received the 
same vein injection of RB and the same surgery, but with-
out exposure to light; thus, no photochemical reaction was 
induced.
3
2. Western blot for Bcl-2, Bax, Caspase-3, pAkt, and survi-
vin
After decapitation, rat brains from different reperfusion 
time points (sham and days 1, 3, and 7) were quickly re-
moved (each group, n=5). The ipsilateral and contralateral 
cerebral cortex was dissected. Samples were flash-frozen 
with liquid nitrogen and were stored at -80°C until analy-
zed. Brain tissues were homogenized and proteins were pu-
rified by using 50 mM Tris-Cl (pH 7.4), 150 mM NaCl, 1 mM 
EDTA, 60 mM n-Octyl-β-D-Glucopyranoside (OGP), and 1 
mM phenylmethylsulfonyl fluoride (PMSF) supplemented 
with a protease inhibitor cocktail (Sigma). To prepare ly-
sates, tissues were sonicated for 4 s for a total of five times 
and the homogenate was spun at 20,000×g for 20 min at 4°C 
to remove insoluble material. Protein concentrations were 
determined with the BCA Protein Assay Reagent Kit 
(Pierce, USA) using bovine serum albumin (BSA) as the 
standard. Equal amounts of nuclear protein (20 μg) for 
Bcl-2, Bax, caspase-3, pAkt (serine-473), and survivin were 
separated on 6% to 12% SDS-polyacrylamide gels (USB 
Fueling Innovation, Cleveland, OH, USA). A PageRuler 
Plus Prestained Protein Ladder
TM (Fermentas Life Sciences, 
Hanover, MD, USA) was used as a size reference. Proteins 
were transferred to pure nitrocellulose membranes (Bio- 
Rad, Richmond, CA, USA). The membranes were incuba-
ted in blocking buffer, 5% nonfat dry milk in TBST (200 mM 
Tris-HCl, pH 7.4, 500 mM NaCl, 0.2% Tween 20), at room 
temperature for 1 h with agitation. The membranes were 
then incubated with rabbit Bcl-2 polyclonal antibody 
(Santa Cruz, 1:2,000 in TBS with 0.2% Tween 20), rabbit 
Bax polyclonal antibody (Millipore, 1:3,000 in TBS with 
0.2% Tween 20), mouse caspase-3 monoclonal antibody 
(Millipore, 1:1,000 in TBS with 0.2% Tween 20), polyclonal 146
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FIG. 2. Relative changes in apoptosis-associated protein expre-
ssion. Data are expressed as the mean±SD expression ratio of the 
ischemic hemisphere to sham controls (n=5, each group). *p＜0.05;
**p＜0.01.
rabbit anti-phopho-Akt antibody (serine-472, Santa Cruz, 
1:5,000 in TBS with 0.2% Tween 20), and mouse survivin 
monoclonal antibody (Santa Cruz, 1:1,000 in TBS with 0.2% 
Tween 20) overnight at 4°C. Following washes, the mem-
branes were incubated with peroxidase-conjugated goat 
anti-mouse or anti-rabbit immunoglobulin (Santa Cruz 
Biotechnology, 1:8,000) in TBS with 0.2% Tween 20 for 1 
h. After rinses in washing buffer, signal of bound antibodies 
was developed by an enhanced Immoblion Western chem-
iluminescent HRP substrate (Millipore, Bedford, MA, 
USA). Quantification of each band was performed by densi-
tometry analysis (Scion, NIH software, Bethesda, MD, 
USA) of the protein signal using LAS 3000. Mouse anti- 
GAPDH monoclonal antibody conjugated with HRP (Sigma, 
1:25,000) was detected on immunoblots as a loading control 
for protein quantitation. 
3. Quantification and statistical analysis
To analyze the amount of the Bcl-2, Bax, caspase-3, pAkt, 
survivin, and GAPDH, we used a relative protein ratio to 
control, and quantitative data were expressed as means±SD. 
Differences between means were determined by one-way 
ANOVA followed by Dunnett’s post hoc test for multiple 
comparisons. p＜0.05 was considered statistically significant. 147
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RESULTS
Ischemia caused changes in the expression of various 
apoptosis-associated proteins depending on the time of study 
(Fig. 1). Notably, the expression of Bax, caspase-3, and 
pAkt proteins was markedly increased in the ischemic 
hemisphere 1 day after the operation compared with that 
in the sham controls. The expression of Bcl-2 and survivin 
was slightly reduced at day 1 and then gradually increased 
by day 3. Bax expression, the bands at 21 kDa, reached peak 
levels at day 3 and gradually decreased by day 7. Caspase-3 
expression, identified at 32 kDa, was abruptly increased 
from day 1 to day 3 compared with the sham control and 
decreased at day 7. pAkt was increased at day 1 but was 
slightly reduced from day 3. The Bcl-2 expression pattern 
was different at different time points. It was slightly re-
duced at day 1, but gradually increased from day 3, and was 
rising on day 7. However, the variation in expression of sur-
vivin, which is an inhibitor apoptosis protein (IAP), was in-
significant compared with the others.
Changes in the density of each apoptosis-associated pro-
tein at each time point are shown in Fig. 2. Bcl-2 protein 
was increased 1.9-fold at day 3 (p＜0.05 versus control) and 
increased 2.8-fold at day 7 (p＜0.05 versus control) in the 
ischemic hemisphere. Bax and pAkt were increased 1.6- 
fold at day 3 and 1.8-fold at day 1, respectively (p＜0.05 ver-
sus control). Caspase-3 was abruptly increased 8.4- to 
9.9-fold from day 1 to day 3 (p＜0.01 versus control), re-
spectively, after the operation. No significant differences 
in survivin levels were found between sham controls and 
the experimental groups.
DISCUSSION
Focal and global cerebral ischemia in rats triggers apop-
totic cell death within the ischemic lesion. In many pre-
vious reports,
1,18 it was shown that new protein synthesis 
appears to be required for apoptosis. Comparison of human 
small cortical infarcts reveals identical histological pat-
terns to photochemically induced rat brain lesions as well 
as naturally occurring human infarcts.
19 Comparatively 
little is known about the apoptotic process in the photo-
chemically induced model, so we evaluated the time point 
expression patterns of the major apoptosis regulatory 
proteins.
The Bcl-2 family of proto-oncogenes encode specific pro-
teins such as Bcl-2, Bcl-XL, and Bax that regulate apop-
tosis. The anti-apoptotic effect of Bcl-2 occurs by prevention 
of cytochrome c release into the cytoplasm.
5 Many studies 
have shown that over-expression of Bcl-2 can reduce ische-
mic brain injury in animal models of stroke.
12,20 Activated 
Bax promotes cell death, unless it is bound by either Bcl-2 
or Bcl-XL.
21 However, the two molecules can act indepen-
dently to exert their effects on cell death.
5 In this study, we 
found strong induction of Bax protein 1 day after infarction 
in the ischemic hemisphere and it reached a peak on day 
3. Compared with Bax expression, Bcl-2 protein expression 
was slightly reduced at day 1 and then abruptly increased 
at day 3 and was sustained at day 7. In a previous report 
using the same stroke model,
15 Bax protein was in the cyto-
plasm of degenerating neurons in the center of the in-
farction between 4 h and 3 days after photothrombosis, and 
at the same time points, the levels of Bcl-2 and Bcl-XL pro-
teins were markedly reduced in this region. These findings 
suggest that Bcl-2 and Bax protein expression switches 
around day 3 in this model. Interestingly, in the MCAo 
mouse model with preconditioning, Bcl-2 and Bcl-Xl were 
increased after sublethal forebrain ischemia but Bax re-
mained unchanged.
22 These differential expressions of the 
Bcl-2 family were associated with animal modeling, such 
as preparing of preconditioning, and reproducibility of le-
thal legion induction. The slight decrease in Bcl-2 expre-
ssion within 1 day might also be attributed to postischemic 
protease activation.
23
Caspases are cysteine proteases that are constitutively 
expressed as zymogens or pro-caspases and that are specif-
ically activated during apoptotic stimuli.
24 Several pre-
vious studies reported that the role of caspase-3 is as a key 
mediator of apoptosis in ischemic stroke.
25 Briefly, upregu-
lation of caspase-3 mRNA in rat brain occurs 1 h after the 
onset of focal ischemia, whereas caspase-3 and its cleavage 
products in mouse brain are activated during early re-
perfusion 2 h after MCAo. Ischemic damage could be re-
duced by caspase inhibitor treatment even 9 h after MCAo. 
We observed a significant increase in the cleaved active 
form of caspase-3 from day 1 of operation until day 3, when 
the maximal intensity was observed (Fig. 2C). Also, this in-
creased caspase-3 expression was sustained at day 7. We 
did not observe any significant change in the contralateral 
hemisphere. These findings are in agreement with an ex-
tended treatment window for caspase inhibition after 
stroke.
18
Akt is a subfamily of serine/threonine protein kinases 
and is activated via phosphatidylinositol-3 kinase (PI3K). 
After phosphorylation, Akt promotes cell survival and pre-
vents apoptosis by inactivating several targets. In the 
MCAo model,
26 phosphorylation of Akt (pAkt) was tempo-
rally accelerated at serine-473 in the ischemic cortex after 
transient focal cerebral ischemia and was then decreased 
by 24 h. However, in the ischemic core, pAkt was decreased 
only after ischemia. pAkt-positive cells were colocalized 
with NeuN-positive cells in the cortex, but pAkt-positive 
cells did not co-localize with TUNEL-positive cells. In this 
study, pAkt expression was increased about 2-fold at day 
1 and was decreased by day 3 compared with the sham 
control. This change in pAkt expression could be explained 
by the propagation of the ischemic lesion. The infarct devel-
ops in the superficial cortex, whereas the higher-order 
branches of the larger patent vessels in the deeper cortical 
layers are occluded by tissue compression caused by the 
vasogenic edema associated with this procedure.
27 Fur-
ther, complete wedge-shaped coagulative necrosis was 
formed 24 h after ischemia according to histopathological 
examination.
28 Thus, as in previously reported studies,
26 148
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pAkt expression in the photochemical-induced stroke mod-
el might also depend on the severity of the ischemia. 
Survivin is a member of the IAP family that serves multi-
ple functions related to both cell survival and cell division 
within many cell types and only recently has come under 
study in relation to ischemia in heart or brain.
29 Recently, 
Zhang et al.
30 reported that this protein is a target for the 
PI3-kinase/Akt pathway and can antagonize the effects of 
apoptosis-inducing factor. On the basis of current knowl-
edge, we hypothesized that survivin would be significantly 
changed in our stroke model, but as noted, the changes in 
survivin expression evaluated by Western blot were in-
significant. In fact, infarct volumes in survivin
＋/− mice at 
24 h and 3 d were not significantly different from those of 
survivin
+/+ mice, which suggests that the role of survivin 
in neuroprotection is minimal.
29
In this study, we evaluated the expression of apoptosis 
regulatory proteins in photochemically induced focal cere-
bral ischemic rat brain. To interpret these changes, we 
have to consider the changes in cerebral blood flow (CBF) 
after photothrombosis. In rats subjected to a photothrom-
botic stroke lesion, cortical CBF at the center of the region 
at risk was gradually reduced until 48 h after irradiation 
with flow values of 33%. However, a significant partial re-
storation of blood flow compared with cCBF values at 24 
h was observed at 72 and 96 h after irradiation. Hence, cort-
ical CBF was 56% of preischemic levels at 72 h and 87% at 
96 h after ischemic induction. These CBF changes could ex-
plain the meaningful changes in Bcl-2, Bax, and caspase-3 
around day 3. 
In conclusion, targeting and preventing apoptosis in the 
penumbra seems to be a rational therapeutic goal for re-
ducing cerebral infarct volume after clinical stroke, and the 
present study may provide the basis for the design of ther-
apeutic interventions using the photochemical thrombosis 
stroke model. However, the expression of each apoptosis 
regulatory protein as well as the regional distribution and 
association with DNA fragmentation should be assessed 
further.
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